PharmaVOICE - 
January 2016
Purchase Issue

In Every Issue
Letter from the Editor
The Year Ahead Last month we identified 10 mega-trends that [...]
By

Taren Grom, Editor

UpFront
Industry at Large Helping Kids with Asthma Medikidz and Meda [...]
By

PharmaVOICE Staff

Innovator’s Corner
Modifying the Immune System for Those with Food Allergies DBV [...]
By

Pierre-Henri Benhamou, CEO and Co-founder, DBV Technologies

mHealth
Quintiles Contributes Open Source Code to ResearchKit  Trending Now: Enhancements [...]
By

PharmaVOICE Staff

What’s New
New Agency Brand Architecture  Trending now:  Publicis Health Media launches [...]
By

PharmaVOICE Staff

Pharma Trax
Adverse Drug Event Reporting in U.S. Plagued by Incompleteness and [...]
By

PharmaVOICE Staff

Tools of the Trade
PerkinElmer Launches Signals for Translational    Trending Now:  New cloud-based [...]
By

PharmaVOICE Staff

The Calendar
Coming Attractions The 7th Annual SCOPE Summit, Feb. 23-25, 2016, [...]
By

PharmaVOICE Staff

Talent Pool
Pharma pool Paul Biondi Bristol-Myers Squibb Appoints Senior VP, Head [...]
By

PharmaVOICE Staff

Last Word
Filling Unmet Needs for Patients David Meek, Executive VP and [...]
By

David Meek, Executive VP and President, Oncology, Baxalta

On The Cover

The Brain: The Decade Ahead
The three-pound organ — made up of more than 100 billion nerves — that serves as the center of the nervous system is one of the most complex parts of the human body. Only recently have researchers and scientists begun to understand the brain and what can go wrong. This special forum kicks off a [...]
By

Denise Myshko and Robin Robinson

Features

The Innovation Spark Catches Fire
Medical innovation can help patients live longer, healthier, and more productive lives. Innovative medicines developed by America’s biopharmaceutical research companies have helped increase childhood cancer survival rates from 58% in 1970 to 83% today and have contributed to declining death rates for patients battling diseases such as HIV/AIDS (85% decline since 1995), heart disease (30% [...]
By

PharmaVOICE Staff

Sales Reps: A Changing Conversation
There are few sectors that have experienced more upheaval than pharmaceutical sales, with Food & Drug Administration rules, evolving healthcare policies, and the movement of many healthcare practitioners from private, independent offices to group practices all contributing to an increasingly challenging sales process, so say the experts at Illuminate. Most in the industry can agree [...]
By

Taren Grom, Editor

Advertising Agency Hot Topics
In late 2015, the American Medical Association called for a ban on DTC advertising of prescription drugs and medical devices, drawing the conclusion that the billions of advertising dollars being spent to promote prescription products was helping to inflate the cost of prescription drugs. Physicians cited concerns that a growing proliferation of ads is driving [...]
By

Taren Grom, Editor

Beyond Pricing: What Payers Want
Value-assessment mechanisms, comparative effectiveness, and health economics and outcomes research are among several factors that are forcing the life-sciences industry to better illustrate the overall value of its products in an attempt to retain some power over insurance reimbursement decisions. As pharmaceutical and biotechnology companies prepare to enter tomorrow’s market, now more than ever, they [...]
By

Robin Robinson

Pharma R&D is Now Biomarker-Driven
Biomarkers are becoming an essential part of the drug discovery and development process. A biomarker-driven approach to developing targeted therapies and patient selection strategies has the potential to increase success in the drug development process, decrease costs, and ultimately improve patient outcomes. The Tufts Center for the Study of Drug Development estimates the cost of [...]
By

Denise Myshko

Despite Turbulence, Brazil Remains A Priority Market
A BRIC nation and the largest economy in South America, Brazil is regarded by most industries as a key market. Starting in the mid-1990s the country entered a period of economic stabilization, followed by strong growth in the early 2000s, driven by the commodities sector. In addition, Brazil experienced significant population growth two to three decades [...]
By

Kim Ribbink

SHOWCASE FEATURE: Social Anxiety
Of the 50 largest pharmaceutical companies worldwide, according to a study by the IMS Institute for Healthcare Informatics, only half are even dabbling in social media. Furthermore, only 10 of these companies are using the big three — Facebook, Twitter, and YouTube — and an even smaller number are interacting with patients in a meaningful [...]
By

Taren Grom, Editor

Hey, Pharma! The Social Train Has Left! Get on the Bus!
Pharma! Time to stop waiting for the long-anticipated social media guidance from the FDA and procrastinating on developing a social brand footprint. Social media is now part of the cost of entry in connecting with your customers. Consumers expect — and are accustomed to — brands being present on the major social platforms and look [...]
By

Martha Walz, VP Content Strategy and Joseph Youssef, Engagement Strategist, Ogilvy CommonHealth, part of Ogilvy CommonHealth Worldwide

Becoming Peers With Professionals On Social Networks
The ecosystem of social networks for healthcare professionals is incredibly diverse. For an increasing number of physicians in the United States, there is no epicenter for online dialogue like Facebook, nor a network with the meteoric growth of SnapChat or Instagram. What is happening is a quickly maturing and a highly specialized web of social [...]
By

Chris Cullman, Senior VP, Engagement Strategist, Ogilvy CommonHealth, part of Ogilvy CommonHealth Worldwide

Reaching Hard-to-Reach Healthcare Professionals: Engage In On-line Communities
Prescribers, pharmacists, and medical directors all have an ongoing need for information on the latest advances in their respective fields. Yet, it is increasingly difficult for life sciences to deliver product information via in-person rep visits; in fact, many busy professionals have a policy against seeing industry sales reps making them hard to reach.  Within [...]
By

Dr. Theodore Search, Pharm. D., Founder, Skipta

FEEDBACK